-
Je něco špatně v tomto záznamu ?
Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor
M. Stepankova, I. Bartonkova, E. Jiskrova, R. Vrzal, S. Mani, S. Kortagere, Z. Dvorak,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.
NLK
Open Access Digital Library
od 1965-07-01
Open Access Digital Library
od 1997-01-01
ROAD: Directory of Open Access Scholarly Resources
PubMed
29626056
DOI
10.1124/mol.118.112151
Knihovny.cz E-zdroje
- MeSH
- buňky Hep G2 MeSH
- cytochrom P-450 CYP1A1 metabolismus MeSH
- indoly farmakologie MeSH
- lidé MeSH
- ligandy MeSH
- messenger RNA metabolismus MeSH
- nádorové buněčné linie MeSH
- promotorové oblasti (genetika) účinky léků MeSH
- receptory aromatických uhlovodíků agonisté antagonisté a inhibitory MeSH
- reportérové geny účinky léků MeSH
- transkripční faktory bHLH agonisté antagonisté a inhibitory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
Novel methylindoles were identified as endobiotic and xenobiotic ligands of the human aryl hydrocarbon receptor (AhR). We examined the effects of 22 methylated and methoxylated indoles on the transcriptional activity of AhRs. Employing reporter gene assays in AZ-AHR transgenic cells, we determined full agonist, partial agonist, or antagonist activities of tested compounds, having substantially variable EC50, IC50, and relative efficacies. The most effective agonists (EMAX relative to 5 nM dioxin) of the AhR were 4-Me-indole (134%), 6-Me-indole (91%), and 7-MeO-indole (80%), respectively. The most effective antagonists of the AhR included 3-Me-indole (IC50; 19 μM), 2,3-diMe-indole (IC50; 11 μM), and 2,3,7-triMe-indole (IC50; 12 μM). Reverse transcription polymerase chain reaction analyses of CYP1A1 mRNA in LS180 cells confirmed the data from gene reporter assays. The compound leads, 4-Me-indole and 7-MeO-indole, induced substantial nuclear translocation of the AhR and enriched binding of the AhR to the CYP1A1 promoter, as observed using fluorescent immunohistochemistry and chromatin immunoprecipitation assays, respectively. Molecular modeling and docking studies suggest the agonists and antagonists likely share the same binding pocket but have unique binding modes that code for their affinity. Binding pocket analysis further revealed that 4-methylindole and 7-methoxyindole can simultaneously bind to the pocket and produce synergistic interactions. Together, these data show a dependence on subtle and specific chemical indole structures as AhR modulators and furthermore underscore the importance of complete evaluation of indole compounds as nuclear receptor ligands.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012735
- 003
- CZ-PrNML
- 005
- 20190416120047.0
- 007
- ta
- 008
- 190405s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1124/mol.118.112151 $2 doi
- 035 __
- $a (PubMed)29626056
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Stepankova, Martina $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
- 245 10
- $a Methylindoles and Methoxyindoles are Agonists and Antagonists of Human Aryl Hydrocarbon Receptor / $c M. Stepankova, I. Bartonkova, E. Jiskrova, R. Vrzal, S. Mani, S. Kortagere, Z. Dvorak,
- 520 9_
- $a Novel methylindoles were identified as endobiotic and xenobiotic ligands of the human aryl hydrocarbon receptor (AhR). We examined the effects of 22 methylated and methoxylated indoles on the transcriptional activity of AhRs. Employing reporter gene assays in AZ-AHR transgenic cells, we determined full agonist, partial agonist, or antagonist activities of tested compounds, having substantially variable EC50, IC50, and relative efficacies. The most effective agonists (EMAX relative to 5 nM dioxin) of the AhR were 4-Me-indole (134%), 6-Me-indole (91%), and 7-MeO-indole (80%), respectively. The most effective antagonists of the AhR included 3-Me-indole (IC50; 19 μM), 2,3-diMe-indole (IC50; 11 μM), and 2,3,7-triMe-indole (IC50; 12 μM). Reverse transcription polymerase chain reaction analyses of CYP1A1 mRNA in LS180 cells confirmed the data from gene reporter assays. The compound leads, 4-Me-indole and 7-MeO-indole, induced substantial nuclear translocation of the AhR and enriched binding of the AhR to the CYP1A1 promoter, as observed using fluorescent immunohistochemistry and chromatin immunoprecipitation assays, respectively. Molecular modeling and docking studies suggest the agonists and antagonists likely share the same binding pocket but have unique binding modes that code for their affinity. Binding pocket analysis further revealed that 4-methylindole and 7-methoxyindole can simultaneously bind to the pocket and produce synergistic interactions. Together, these data show a dependence on subtle and specific chemical indole structures as AhR modulators and furthermore underscore the importance of complete evaluation of indole compounds as nuclear receptor ligands.
- 650 _2
- $a transkripční faktory bHLH $x agonisté $x antagonisté a inhibitory $7 D051792
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a cytochrom P-450 CYP1A1 $x metabolismus $7 D019363
- 650 _2
- $a reportérové geny $x účinky léků $7 D017930
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a indoly $x farmakologie $7 D007211
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a promotorové oblasti (genetika) $x účinky léků $7 D011401
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a receptory aromatických uhlovodíků $x agonisté $x antagonisté a inhibitory $7 D018336
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
- 700 1_
- $a Bartonkova, Iveta $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
- 700 1_
- $a Jiskrova, Eva $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
- 700 1_
- $a Vrzal, Radim $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
- 700 1_
- $a Mani, Sridhar $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.) moulin@email.cz sridhar.mani@einstein.yu.edu.
- 700 1_
- $a Kortagere, Sandhya $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.).
- 700 1_
- $a Dvorak, Zdenek $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic (M.S., I.B., E.J., R.V., Z.D.); Departments of Genetics and Medicine, Albert Einstein College of Medicine, Bronx, New York (S.M.); and Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania (S.K.) moulin@email.cz sridhar.mani@einstein.yu.edu.
- 773 0_
- $w MED00003399 $t Molecular pharmacology $x 1521-0111 $g Roč. 93, č. 6 (2018), s. 631-644
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29626056 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190416120112 $b ABA008
- 999 __
- $a ok $b bmc $g 1392045 $s 1051040
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 93 $c 6 $d 631-644 $e 20180406 $i 1521-0111 $m Molecular pharmacology $n Mol Pharmacol $x MED00003399
- LZP __
- $a Pubmed-20190405